why choose us

First received: January 10, 2024

Clinical Trial: A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prurigo Nodularis

Study Type: INTERVENTIONAL


Official Title: A Maximal Use Trial of Ruxolitinib Cream in Adult Participants With Prurigo Nodularis

Brief Summary: This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Prurigo Nodularis (PN).

Read more